Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study
On the heels of his study, Dr. James Berenson —– an oncologist specializing in multiple…
read more
IMBCR & Emory University’s Big Discovery!!!
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response…
read more
James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center
New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative…
read more